Medical Device Link.

Maximizing Your Company’s Sale Price

During this volatile recession, the majority of business owners in the middle-market (companies valued between $5,000,000 and $100,000,000) have seen a significant reduction in their companies’ value. Business owners’ most valuable possessions—the businesses—are not worth what they once were. Even though owners have seen business value erode, it is important that they understand that there are methods to minimize the damage from the recession and ways to maximize a company’s sale price.

Surveying the Reimbursement ‘Landscape’
Address coding, coverage policies, payment methods, and other reimbursement questions early in a device’s life cycle. Amir Inbar demystifies the reimbursement process by providing the eight critical steps required for the reimbursement of any medical device.

Court Case on Patent Delays Holds Appeal for Industry
In certain business sectors, particularly the medical device, pharmaceutical, and biotechnology spaces, extending the term of a patent by a year or even by a few months can dramatically improve the bottom line. This is particularly true where sales are thriving as the successful medical device or drug is about to come off patent—just when generics manufacturers and other industry players prepare to enter the field and snatch market share.

CEOs Shy Away From Breakthrough Technology
Although there is much uncertainty surrounding the outcomes of economic recovery and healthcare reform, the CEOs of four bioscience companies must adjust for the future now. On September 14, the leaders of Bio-Optronics, ConMed, Greatbatch, and Welch Allyn participated in the discussion, “Just What the Doctor Ordered: CEOs and Their Prescription for Success in a Changing Economy.” The Web conference was hosted by industry organization MedTech.

PEAK Surgical Inc. and Medtronic Inc. have reached an agreement that grants the Surgical Technologies business at Medtronic exclusive rights for global distribution and marketing of the PEAK PlasmaBlade TnA (Tonsil and Adenoid) tissue dissection device for the ear, nose, and throat market. Read more.

ResMed, which makes products to treat sleep apnea and other respiratory problems, has reported that it will aqcuire Lyon, France-based Laboratoires Narval for €8 million ($12 million). Read more.

Franklin & Seidelmann Subspecialty Radiology has raised $12.5 millionto expand into new markets and add services. Details of the money-raise have not been disclosed. Read more.

Edwards Lifesciences Corp. has announced its intentions to develop a state-of-the-art manufacturing facility in Draper, UT. Read more.